Innovation at UCSD Detects Hidden Killer and Opens Door to Early Interventions
Host Beth Friedman talks with Dr. Jorge Silva, Cardiologist, Professor, and Director of the Hypertrophic Cardiomyopathy Program at UC San Diego Health. Their conversation uncovers a new AI tool being used at UCSD to help cardiologists identify a hidden killer – hypertrophic cardiomyopathy. It’s one of healthcare’s most misleading and under-diagnosed conditions….and also the #1 cause of cardiovascular death in people under the age of 35.
Listen to the Conversation
Takeaways
- Hypertrophic Cardiomyopathy (HCM) is a leading cause of cardiovascular death under 35. It often goes undiagnosed and affects 1 in 500 people, with genetic and non-genetic origins.
- Early detection of HCM is crucial to prevent severe complications, and new AI technology from Viz.ai has significantly improved diagnostic accuracy.
- Treatment for HCM involves monitoring and medications, with new FDA-approved therapies offering hope for better outcomes, especially for younger patients.
- The FDA-approved Viz AI tool has increased HCM detection rates by 80%, enabling earlier and less invasive treatments, particularly benefiting underserved populations.
- The use of AI in cardiology will enhance diagnostic precision, save doctors time, and shift the focus from treatment to prevention through early detection and intervention.
About the Show
FINN Voices
Amplifying the power of health innovation to improve people’s lives.
FINN Voices amplifies the power of health innovation and information technology. Hosted by health experts from FINN Partners, each episode offers a peek behind the curtain of innovation with healthcare’s leading changemakers. We talk about their ideas and challenges along the way; continually shaping critical conversations and introducing the new health technologies that lie ahead.
Follow the show’s hashtag #FINNvoices
